Factors associated with the author-reported cost-effectiveness threshold in high-income countries: systematic review and multivariable modelling
Nicolas Boespflug,
Jérôme Wittwer and
Antoine Bénard ()
Additional contact information
Nicolas Boespflug: CHU Bordeaux, Service d’information Médicale, USMR & CIC-EC 1401
Jérôme Wittwer: INSERM, Bordeaux Population Health, UMR 1219
Antoine Bénard: CHU Bordeaux, Service d’information Médicale, USMR & CIC-EC 1401
The European Journal of Health Economics, 2024, vol. 25, issue 4, No 6, 639 pages
Abstract:
Abstract Objective The cost-effectiveness threshold (CET) is a key parameter to guide objective reimbursement decisions, yet very few countries have defined a reference CET, and there is no reference method for defining it. Our objective was to determine the factors explaining the author-reported CETs in the literature. Methods Our systematic review targeted original articles referenced in EMBASE and published between 2010 and 2021. Selected studies had to use Quality-Adjusted Life-Year (QALY), and being conducted in high-income countries. Our explanatory variables were: estimated cost-effectiveness ratio (ICER), region of the world, source of funding, type of intervention, disease, year of publication, justification of the author-reported Cost-Effectiveness Threshold (ar-CET), economic perspective, and declaration of interest. Multivariable linear regression models implemented on R software were used, guided by a Directed Acyclic Graph. Results Two hundred and fifty four studies were included. The mean ar-CET was €63,338/QALY (standard deviation (SD) 34,965) overall, and €37,748/QALY (SD 20,750) in studies conducted in the British Commonwealth. The ar-CET increased slightly with the ICER (+ 66€/QALY for each additional 10,000€/QALY in the ICER, 95% confidence interval (IC) [31–102], p
Keywords: Systematic review; Multivariable modelling; Cost-effectiveness threshold; Cost-effectiveness analyses; Medical devices; Drugs (search for similar items in EconPapers)
Date: 2024
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
http://link.springer.com/10.1007/s10198-023-01613-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:25:y:2024:i:4:d:10.1007_s10198-023-01613-7
Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2
DOI: 10.1007/s10198-023-01613-7
Access Statistics for this article
The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg
More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().